Optimal Management of Dysphagia in Patients with Inoperable Esophageal Cancer: Current Perspectives

References

• Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432–443. doi:10.1038/s41575-021-00419-3
   PubMed Web of Science ®Google Scholar
• Howlade N, NooneAM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD. Available from: https://seer.cancer.gov/csr/1975_2016/. Accessed April 5, 2022.
   Google Scholar
• Kauppila JH, Mattsson F, Brusselaers N, Lagergren J. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study. BMJ Open. 2018;8(5):e021495. doi:10.1136/bmjopen-2018-021495
   PubMed Web of Science ®Google Scholar
• Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R; Association of Upper Gastrointestinal Surgeons of Great, t. B. S. o. G. Ireland and O. The British Association of Surgical. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60(11):1449–1472. doi:10.1136/gut.2010.228254
   PubMed Web of Science ®Google Scholar
• Alexander P, Mayoral W, Reilly HF, Wadleigh R, Trachiotis G, Lipman TO. Endoscopic Nd: YAG laser with aggressive multimodality therapy for locally advanced esophageal cancer. Gastrointest Endosc. 2002;55(6):674–679. doi:10.1067/mge.2002.123270
   PubMed Web of Science ®Google Scholar
• Javle M, Ailawadhi S, Yang GY, Nwogu CE, Schiff MD, Nava HR. Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol. 2006;4(8):365–373, 379.
   PubMedGoogle Scholar
• Rabenstein T. Palliative endoscopic therapy of esophageal cancer. Viszeralmedizin. 2015;31(5):354–359. doi:10.1159/000441175
   PubMedGoogle Scholar
• Levy A, Wagner AD, Chargari C, et al. Palliation of dysphagia in metastatic oesogastric cancers: an international multidisciplinary position. Eur J Cancer. 2020;135:103–112. doi:10.1016/j.ejca.2020.04.032
   PubMed Web of Science ®Google Scholar
• Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy. Arch Intern Med. 1985;145(8):1443–1446.
   PubMedGoogle Scholar
• Rutgeerts P, Vantrappen G, Broeckaert L, et al. Palliative Nd: YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life. Gastrointest Endosc. 1988;34(2):87–90. doi:10.1016/s0016-5107(88)71269-9
   PubMed Web of Science ®Google Scholar
• Mason RC, Bright N, McColl I. Palliation of malignant dysphagia with laser therapy: predictability of results. Br J Surg. 1991;78(11):1346–1347. doi:10.1002/bjs.1800781125
   PubMed Web of Science ®Google Scholar
• Konigsrainer A, Riedmann B, De Vries A, et al. Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer: a prospective randomized trial. Hepatogastroenterology. 2000;47(33):724–727.
   PubMedGoogle Scholar
• Pozza A, Erroi FR, Scarpa M, Polese L, Rampazzo L, Norberto L. Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome. Updates Surg. 2015;67(1):61–67. doi:10.1007/s13304-015-0277-4
   PubMedGoogle Scholar
• Gevers AM, Macken E, Hiele M, Rutgeerts P. A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula. Gastrointest Endosc. 1998;48(4):383–388. doi:10.1016/s0016-5107(98)70007-0
   PubMed Web of Science ®Google Scholar
• Marcon NE. Photodynamic therapy and cancer of the esophagus. Semin Oncol. 1994;21(6 Suppl 15):20–23.
   PubMed Web of Science ®Google Scholar
• Heier SK, Rothman KA, Heier LM, Rosenthal WS. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd: yAGlaser therapy. Gastroenterology. 1995;109(1):63–72. doi:10.1016/0016-5085(95)90269-4
   PubMed Web of Science ®Google Scholar
• Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAGlaser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc. 1995;42(6):507–512. doi:10.1016/s0016-5107(95)70002-1
   PubMed Web of Science ®Google Scholar
• Lecleire S, Di Fiore F, Antonietti M, et al. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent. Am J Gastroenterol. 2008;103(9):2215–2219. doi:10.1111/j.1572-0241.2008.02042.x
   PubMed Web of Science ®Google Scholar
• Li LB, Xie JM, Zhang XN, et al. Retrospective study of photodynamic therapy vs photodynamic therapy combined with chemotherapy and chemotherapy alone on advanced esophageal cancer. Photodiagnosis Photodyn Ther. 2010;7(3):139–143. doi:10.1016/j.pdpdt.2010.06.002
   PubMed Web of Science ®Google Scholar
• Wahab PJ, Mulder CJ, den Hartog G, Thies JE. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy. 1997;29(3):176–181. doi:10.1055/s-2007-1004159
   PubMed Web of Science ®Google Scholar
• Heindorff H, Wojdemann M, Bisgaard T, Svendsen LB. Endoscopic palliation of inoperable cancer of the oesophagus or cardia by argon electrocoagulation. Scand J Gastroenterol. 1998;33(1):21–23. doi:10.1080/00365529850166158
   PubMed Web of Science ®Google Scholar
• Akhtar K, Byrne JP, Bancewicz J, Attwood SE. Argon beam plasma coagulation in the management of cancers of the esophagus and stomach. Surg Endosc. 2000;14(12):1127–1130. doi:10.1007/s004640000266
   PubMed Web of Science ®Google Scholar
• Eickhoff A, Jakobs R, Schilling D, et al. Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC. Endoscopy. 2007;39(7):637–642. doi:10.1055/s-2007-966571
   PubMed Web of Science ®Google Scholar
• Rupinski M, Zagorowicz E, Regula J, et al. Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II). Am J Gastroenterol. 2011;106(9):1612–1620. doi:10.1038/ajg.2011.178
   PubMed Web of Science ®Google Scholar
• Kofoed SC, Lundsgaard M, Ellemann AC, Svendsen LB. Low morbidity after palliation of obstructing gastro-oesophageal adenocarcinoma to restore swallowing function. Dan Med J. 2012;59(6):A4434.
   PubMed Web of Science ®Google Scholar
• Greenwald BD, Dumot JA, Abrams JA, et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc. 2010;71(4):686–693. doi:10.1016/j.gie.2010.01.042
   PubMed Web of Science ®Google Scholar
• Kachaamy T, Prakash R, Kundranda M, et al. Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer. Gastrointest Endosc. 2018;88(3):447–455. doi:10.1016/j.gie.2018.04.2362
   PubMed Web of Science ®Google Scholar
• Shah T, Kushnir V, Mutha P, et al. Neoadjuvant cryotherapy improves dysphagia and may impact remission rates in advanced esophageal cancer. Endosc Int Open. 2019;7(11):E1522–E1527. doi:10.1055/a-0957-2798
   PubMed Web of Science ®Google Scholar
• Swathi Eluri VK, Sharma NR, Gordon SR, et al. Palliative endoscopic spray cryotherapy to prevent worsening of dysphagia and improve quality of life in esophageal cancer [Abstract]. American Society of Clinical Oncology (ASCO) Annual Meeting Chicago; 2021.
   Google Scholar
• Kachammy T, Shaw SN, Mohapatra S, et al. Cryotherapy is safe and effective without causing reflux symptoms in esophageal cancer patients receiving systemic therapy; intensive therapy showed greater benefit: a prospective multicenter study [Abstract]. Digestive Disease Week San Diego; 2022.
   Google Scholar
• Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014;(10):CD005048. doi:10.1002/14651858.CD005048.pub4
   PubMed Web of Science ®Google Scholar
• Evans JA, Early DS, Chandraskhara V, et al.; Committee, A. S. o. P. American Society for Gastrointestinal. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc. 2013;77(3):328–334. doi:10.1016/j.gie.2012.10.001
   PubMed Web of Science ®Google Scholar
• Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48(10):939–948. doi:10.1055/s-0042-114210
   PubMed Web of Science ®Google Scholar
• Spaander MCW, van der Bogt RD, Baron TH, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2021. Endoscopy. 2021;53(7):751–762. doi:10.1055/a-1475-0063
   PubMed Web of Science ®Google Scholar
• Guo JH, Teng GJ, Zhu GY, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008;247(2):574–581. doi:10.1148/radiol.2472070999
   PubMed Web of Science ®Google Scholar
• Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW. Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time. Endoscopy. 2019;51(1):18–29. doi:10.1055/a-0644-2495
   PubMed Web of Science ®Google Scholar
• Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol. 2001;12(4):465–474. doi:10.1016/s1051-0443(07)61886-7
   PubMed Web of Science ®Google Scholar
• Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci. 2008;53(2):334–340. doi:10.1007/s10620-007-9862-9
   PubMed Web of Science ®Google Scholar
• Persson J, Smedh U, Johnsson A, et al. Fully covered stents are similar to semi-covered stents with regard to migration in palliative treatment of malignant strictures of the esophagus and gastric cardia: results of a randomized controlled trial. Surg Endosc. 2017;31(10):4025–4033. doi:10.1007/s00464-017-5441-0
   PubMed Web of Science ®Google Scholar
• Wang C, Wei H, Li Y. Comparison of fully-covered vs partially covered self-expanding metallic stents for palliative treatment of inoperable esophageal malignancy: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):73. doi:10.1186/s12885-020-6564-6
   PubMed Web of Science ®Google Scholar
• Pandit S, Samant H, Morris J, Alexander SJ. Efficacy and safety of standard and anti-reflux self-expanding metal stent: a systematic review and meta-analysis of randomized controlled trials. World J Gastrointest Endosc. 2019;11(4):271–280. doi:10.4253/wjge.v11.i4.271
   PubMed Web of Science ®Google Scholar
• Shamji FM, Inculet R. Management of malignant tracheoesophageal fistula. Thorac Surg Clin. 2018;28(3):393–402. doi:10.1016/j.thorsurg.2018.04.007
   PubMed Web of Science ®Google Scholar
• Nomori H, Horio H, Imazu Y, Suemasu K. Double stenting for esophageal and tracheobronchial stenoses. Ann Thorac Surg. 2000;70(6):1803–1807. doi:10.1016/s0003-4975(00)02042-7
   PubMed Web of Science ®Google Scholar
• Fuccio L, Mandolesi D, Farioli A, et al. Brachytherapy for the palliation of dysphagia owing to esophageal cancer: a systematic review and meta-analysis of prospective studies. Radiother Oncol. 2017;122(3):332–339. doi:10.1016/j.radonc.2016.12.034
   PubMed Web of Science ®Google Scholar
• Sharma V, Mahantshetty U, Dinshaw KA, Deshpande R, Sharma S. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;52(2):310–315. doi:10.1016/s0360-3016(01)01822-3
   PubMed Web of Science ®Google Scholar
• Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53(1):127–133. doi:10.1016/s0360-3016(02)02702-5
   PubMed Web of Science ®Google Scholar
• Suntharalingam M, Moughan J, Coia LR, et al.; Patterns of Care. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996–1999 Patterns of Care Study. Int J Radiat Oncol Biol Phys. 2003;56(4):981–987. doi:10.1016/s0360-3016(03)00256-6
   PubMed Web of Science ®Google Scholar
• Fuccio L, Guido A, Hassan C, et al. Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey. Dig Liver Dis. 2016;48(10):1233–1236. doi:10.1016/j.dld.2016.07.003
   PubMedGoogle Scholar
• Murray LJ, Din OS, Kumar VS, Dixon LM, Wadsley JC. Palliative radiotherapy in patients with esophageal carcinoma: a retrospective review. Pract Radiat Oncol. 2012;2(4):257–264. doi:10.1016/j.prro.2011.12.002
   PubMedGoogle Scholar
• Bown SG. Palliation of malignant dysphagia: surgery, radiotherapy, laser, intubation alone or in combination? Gut. 1991;32(8):841–844. doi:10.1136/gut.32.8.841
   PubMed Web of Science ®Google Scholar
• Hanna WC, Sudarshan M, Roberge D, et al. What is the optimal management of dysphagia in metastatic esophageal cancer? Curr Oncol. 2012;19(2):e60–e66. doi:10.3747/co.19.892
   PubMed Web of Science ®Google Scholar
• Suzuki G, Yamazaki H, Aibe N, et al. Palliative Radiotherapy in the Local Management of Stage IVB Esophageal Cancer: factors Affecting Swallowing and Survival. Anticancer Res. 2017;37(6):3085–3092. doi:10.21873/anticanres.11664
   PubMed Web of Science ®Google Scholar
• Jeene PM, Vermeulen BD, Rozema T, et al. Short-course external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials. J Thorac Oncol. 2020;15(8):1361–1368. doi:10.1016/j.jtho.2020.04.032
   PubMed Web of Science ®Google Scholar
• Sur R, Donde B, Falkson C, et al. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy. 2004;3(4):191–195. doi:10.1016/j.brachy.2004.09.004
   PubMedGoogle Scholar
• Rosenblatt E, Jones G, Sur RK, et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol. 2010;97(3):488–494. doi:10.1016/j.radonc.2010.09.001
   PubMed Web of Science ®Google Scholar
• Welsch J, Kup PG, Nieder C, et al. Survival and symptom relief after palliative radiotherapy for esophageal cancer. J Cancer. 2016;7(2):125–130. doi:10.7150/jca.13655
   PubMed Web of Science ®Google Scholar
• Vermeulen BD, Jeene PM, Sijben J, et al. Low-dose versus high-dose radiation therapy for the palliation of dysphagia from esophageal cancer: a multicenter retrospective cohort study. Pract Radiat Oncol. 2020;10(4):e255–e263. doi:10.1016/j.prro.2019.10.010
   PubMed Web of Science ®Google Scholar
• Javed A, Pal S, Dash NR, et al. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial. J Gastrointest Cancer. 2012;43(1):63–69. doi:10.1007/s12029-010-9206-4
   PubMedGoogle Scholar
• Ng TM, Spencer GM, Sargeant IR, Thorpe SM, Bown SG. Management of strictures after radiotherapy for esophageal cancer. Gastrointest Endosc. 1996;43(6):584–590. doi:10.1016/s0016-5107(96)70196-7
   PubMed Web of Science ®Google Scholar
• Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(7):855–883. doi:10.6004/jnccn.2019.0033
   PubMed Web of Science ®Google Scholar
• Ilson DH, Saltz L, Enzinger P, et al. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol. 1999;17(10):3270–3275. doi:10.1200/JCO.1999.17.10.3270
   PubMed Web of Science ®Google Scholar
• Ilson DH, Forastiere A, Arquette M, et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J. 2000;6(5):316–323.
   PubMed Web of Science ®Google Scholar
• Cwikiel M, Cwikiel W, Albertsson M. Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol. 1996;35(1):75–79. doi:10.3109/02841869609098483
   PubMed Web of Science ®Google Scholar
• Penniment MG, De Ieso PB, Harvey JA, et al.; T. C. E. group. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018;3(2):114–124. doi:10.1016/S2468-1253(17)30363-1
   PubMed Web of Science ®Google Scholar
• Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–1598. doi:10.1056/NEJM199206113262403
   PubMed Web of Science ®Google Scholar
• Alsina M, Moehler M, Lorenzen S. Immunotherapy of esophageal cancer: current status, many trials and innovative strategies. Oncol Res Treat. 2018;41(5):266–271. doi:10.1159/000488120
   PubMed Web of Science ®Google Scholar
• Kakeji Y, Oshikiri T, Takiguchi G, et al. Multimodality approaches to control esophageal cancer: development of chemoradiotherapy, chemotherapy, and immunotherapy. Esophagus. 2021;18(1):25–32. doi:10.1007/s10388-020-00782-1
   PubMed Web of Science ®Google Scholar
• Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364(9444):1497–1504. doi:10.1016/S0140-6736(04)17272-3
   PubMed Web of Science ®Google Scholar
• Bergquist H, Wenger U, Johnsson E, et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus. 2005;18(3):131–139. doi:10.1111/j.1442-2050.2005.00467.x
   PubMed Web of Science ®Google Scholar
• Polinder S, Homs MY, Siersema PD, Steyerberg EW, Dutch SSG. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer. 2004;90(11):2067–2072. doi:10.1038/sj.bjc.6601815
   PubMed Web of Science ®Google Scholar
• Song HY, Lee DH, Seo TS, et al. Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol. 2002;13(3):285–293. doi:10.1016/s1051-0443(07)61722-9
   PubMed Web of Science ®Google Scholar
• Eldeeb H, El-Hadaad HA. Radiotherapy versus stenting in treating malignant dysphagia. J Gastrointest Oncol. 2012;3(4):322–325. doi:10.3978/j.issn.2078-6891.2012.011
   PubMedGoogle Scholar
• Rueth NM, Shaw D, D’Cunha J, Cho C, Maddaus MA, Andrade RS. Esophageal stenting and radiotherapy: a multimodal approach for the palliation of symptomatic malignant dysphagia. Ann Surg Oncol. 2012;19(13):4223–4228. doi:10.1245/s10434-012-2459-3
   PubMed Web of Science ®Google Scholar
• Qiu G, Tao Y, Du X, et al. The impact of prior radiotherapy on fatal complications after self-expandable metallic stents (SEMS) for malignant dysphagia due to esophageal carcinoma. Dis Esophagus. 2013;26(2):175–181. doi:10.1111/j.1442-2050.2012.01348.x
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Nagata K, Katano S, et al.; Japanese Society for Esophageal. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys. 2003;56(5):1327–1332. doi:10.1016/s0360-3016(03)00198-6
   PubMed Web of Science ®Google Scholar
• Touchefeu Y, Archambeaud I, Landi B, et al. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer. Dig Liver Dis. 2014;46(3):283–286. doi:10.1016/j.dld.2013.10.012
   PubMedGoogle Scholar
• Didden P, Spaander MC, Kuipers EJ, Bruno MJ. Safety of stent placement in recurrent or persistent esophageal cancer after definitive chemoradiotherapy: a case series. Gastrointest Endosc. 2012;76(2):426–430. doi:10.1016/j.gie.2012.03.004
   PubMed Web of Science ®Google Scholar
• Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speiser B. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys. 1997;38(1):127–132. doi:10.1016/s0360-3016(97)00231-9
   PubMed Web of Science ®Google Scholar